Tumor necrosis factor-alpha gene promoter-308G/A and-238G/A polymorphisms in Mexican patients with type 2 diabetes mellitus

Disease Markers

Volumn 30, Issue 1, 2011, Pages 19-24

  Guzmán Flores, Juan Manuel ^a   Muoz Valle, José Francisco ^b   Sánchez Corona, José ^a   Cobián, José G ^c   Medina Carrillo, Leopoldo ^a   G García Zapién, Alejandra ^a   Cruz Quevedo, Edhit G ^a   Flores Martínez, Silvia Esperanza ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c Hospital General de Zona IMSS   (Mexico)

Author keywords

Haplotype; Mexican patients; polymorphism; TNF alpha; Type 2 diabetes mellitus

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 79955085794     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0759     Document Type: Article

References (34)

1. The International Diabetes Federation, Available at: http://www. diabetesatlas.org; Accessed 25 May 2010.
2. S.E. Shoelson, J. Lee and A.B. Goldfine, Inflammation and insulin resistance, J Clin Invest 116 (2006), 1793-1801. (Pubitemid 44033299)
3. J.M. Fernandez-Real and J.C. Pickup, Innate immunity, insulin resistance and type 2 diabetes, Trends Endocrinol Metab 19 (2008), 10-16.
4. L. Bertazza and S. Mocellin, Tumor necrosis factor (TNF) biology and cell death, Front Biosci 13 (2008), 2736-2743. (Pubitemid 351611605)
5. G.S. Hotamisligil, N.S. Shargill and B.M. Spiegelman, Adipose expression oftumor necrosis factor-alpha: direct role in obesity-linked insulin resistance, Science 259 (1993), 87-91. (Pubitemid 23036092)
6. D.E. Moller, Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes, Trends Endocrinol Metab 11 (2000), 212-217. (Pubitemid 30603166)
7. P. Gual, Y. Le Marchand-Brustel and J.F. Tanti, Positive and negative regulation of insulin signaling through IRS-1 phosphorylation, Biochimie 87 (2005), 99-109. (Pubitemid 40298772)
8. G.S. Hotamisligil, Inflammation and metabolic disorders, Nature 444 (2006), 860-867. (Pubitemid 46024993)
9. S.C. Sookoian, C. Gonzalez and CJ. Pirola, Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated withthe metabolic syndrome, Obes Res 13 (2005), 2122-2131.
10. R. Feng, Y. Li, D. Zhao, C. Wang, Y. Niu and C. Sun, Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis, Acta Diabetol 46 (2009), 339-343.
11. A.G. Wilson, F.S. di Giovine, A.I. Blakemore and G.W. Duff, Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by Nco I restriction of PCR product, Hum Mol Genet 1 (1992), 353.
12. S. D'Alfonso and PM. Richiardi, A polymorphic variation in a putative regulation box of the TNFA promoter region, Immunogenetics 39 (1994), 150-154. (Pubitemid 23344817)
13. Diagnosis and classification of diabetes mellitus, Diabetes Care 33(Suppl 1)(2010), S62-S69.
14. C. Gorodezky, C. Alaez, M.N. Vazquez-Garcia, G. de la Rosa, E. Infante, S. Balladares, R. Toribio, E. Perez-Luque and L. Munoz, The genetic structure of Mexican Mestizos ofdifferent locations: tracking back their origins through MHC genes, blood group systems, and microsatellites, Hum Immunol 62 (2001), 979-991. (Pubitemid 32835062)
15. S. Gustincich, G. Manfioletti, G. Del Sal, C. Schneider and P. Carninci, A fast method for high-quality genomic DNA extraction from whole human blood,Biotechniques 11 (1991), 298-300.
16. CP. Day, J. Grove, A.K. Daly, M.W. Stewart, PJ. Avery and M. Walker, Tumour necrosis factor-alpha gene promoter poly-morphism and decreased insulin resistance, Diabetologia 41 (1998), 430-434. (Pubitemid 28157414)
17. L. Excoffier, G. Laval and S. Schneider, Arlequin (version 3.0): An integrated software package for population genetics data analysis, Evol Bioinform Online 1 (2005), 47-50.
18. J.P Bayley, H. de Rooij, PJ. van den Elsen, T.W. Huizinga and CL. Verweij, Functional analysis oflinker-scan mutants spanningthe\376,\308,\244, and\238 polymorphic sites ofthe TNF-alpha promoter, Cytokine 14 (2001), 316-323. (Pubitemid 32730472)
19. A.R. Suriano, A.N. Sanford, N. Kim, M. Oh, S. Kennedy, MJ. Henderson, K. Dietzmann and K.E. Sullivan, GCF2/LRRFIP1 represses tumor necrosis factor alpha expression, Mol Cell Biol25 (2005), 9073-9081. (Pubitemid 41429095)
20. W. Kaluza, E. Reuss, S. Grossmann, R. Hug, R.E. Schopf, PR. Galle, E. Maerker-Hermann and T. Hoehler. Different tran-scriptional activity and in vitro TNF-alpha production in pso-riasis patients carrying the TNF-alpha 238A promoter poly-morphism, J Invest Dermatol 114(2000), 1180-1183. (Pubitemid 30415236)
21. A. Hamann, C. Mantzoros, A. Vidal-Puig and J.S. Flier, Ge-netic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM), Biochem Biophys Res Commun211 (1995), 833-839.
22. M. Furuta, Y Yano, K. Ito, E.C. Gabazza, A. Katsuki, T. Tanaka, K. Ohtake, N. Hirata, Y Hori, R. Araki-Sasaki, Y Sumida and Y Adachi, Relationship of the tumor necrosis factor-alpha\308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus, Diabetes Res Clin Pract 56 (2002), 141-145. (Pubitemid 34226630)
23. G.T. Ko, S.C. Lee, YB. Pu, M.C. Ng, W.Y. So, N. Thomas, W.B. Chan, CS. Cockram and J.C. Chan, Tumour necrosis factor-alpha promoter gene polymorphism at\308 (genotype AA) in Chinese subjects with Type 2 diabetes, Diabet Med20 (2003), 167-168. (Pubitemid 36269661)
24. M.Y. Shiau, CY. Wu, CN. Huang, S.W. Hu, SJ. Lin and YH. Chang, TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients, Tissue Antigens 61 (2003), 393-397.
25. A. Tsiavou, E. Hatziagelaki, A. Chaidaroglou, A. Manginas, K. Koniavitou, D. Degiannis and S.A. Raptis, TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoim-mune diabetes of adults (LADA) and type 2 diabetes mellitus, J Clin Immunol 24 (2004), 591-599. (Pubitemid 40933110)
26. MJ. Santos, G.A. Patino, B.B. Angel, HJ. Martinez, B.F. Perez, B.A. Villarroel, A.L. Sierrasesumaga and B.C. Albala, [Association between tumor necrosis factor-alpha promoter polymorphisms and type 2 diabetes and obesity in Chilean elderly women], Rev Med Chil134 (2006), 1099-1106. (Pubitemid 44800166)
27. E. Zeggini, CJ. Groves, J.R. Parkinson, S. Halford, K.R. Owen, T.M. Frayling, M. Walker, G.A. Hitman, J.C. Levy, S. O'Rahilly, A.T. Hattersley and M.I. McCarthy, Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes, Diabetologia 48 (2005), 2013-2017. (Pubitemid 41416911)
28. R. Bouhaha, T. Baroudi, H. Ennafaa, E. Vaillant, H. Abid, R. Sassi, V. Vatin, P. Froguel, A.B. Gaaied, D. Meyre and M. Vaxillaire, Study ofTNFalpha\308G/A and IL6\174G/C poly-morphisms in type 2 diabetes and obesity risk in the Tunisian population, Clin Biochem 43 (2010), 549-552.
29. V.K. Kolla, G. Madhavi, R.B. Pulla, B.M. Srikanth Babu, J. Yashovanthi, V.L. Valluri, J. Ramesh and J. Akka, Association of tumor necrosis factor alpha, interferon gamma and inter-leukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients withtype 2 diabetes, Cytokine 47 (2009), 173-177.
30. A. Mahajan, R. Tabassum, S. Chavali, O.P Dwivedi, G. Chauhan, N. Tandon and D. Bharadwaj, Obesity-dependent association of TNF-LTA locus with type 2 diabetes in North Indians, JMol Med88 (2010), 515-522.
31. B.T Heijmans, R.G. Westendorp, S. Droog, C. Kluft, D.L. Knook and PE. Slagboom, Association ofthe tumour necrosis factor alpha\308G/A polymorphism with the risk ofdiabetes in an elderly population-based cohort, Genes Immun 3 (2002), 225-228. (Pubitemid 38961135)
32. B. Fontaine-Bisson, TM. Wolever, J.L. Chiasson, R. Rabasa-Lhoret, P. Maheux, R.G. Josse, L.A. Leiter, N.W. Rodger, E.A. Ryan and A. El-Sohemy, Tumor necrosis factor alpha\238G>A genotype alters postprandial plasma levels offree fatty acids in obese individuals with type 2 diabetes mellitus, Metabolism 56 (2007), 649-655. (Pubitemid 46574727)
33. H. Li, L. Groop, A. Nilsson, J. Weng and T. Tuomi, A combi-nation ofhuman leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predis-poses to an insulin-deficient phenotype in patients with type 2 diabetes, J Clin Endocrinol Metab 88 (2003), 2767-2774. (Pubitemid 36724454)
34. S.K. Rasmussen, S.A. Urhammer, J.N. Jensen, T. Hansen, K. Borch-Johnsen and O. Pedersen, The\238 and\308 G->A polymorphisms of the tumor necrosis factor alpha gene pro-moter are not associated with features ofthe insulin resistance syndrome or altered birth weight in Danish Caucasians, J Clin Endocrinol Metab 85 (2000), 1731-1734. (Pubitemid 32289526)